MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2
Ling Ding, Yanjun Xu(Zhejiang University), Wei Zhang(Zhejiang University), Yujie Deng(Zhejiang University), Misi Si(Zhejiang University), Ying Du(Zhejiang University), Haomi Yao(Sir Run Run Shaw Hospital), Xuyan Liu(Zhejiang University), Yuehai Ke(Zhejiang University), Jianmin Si(Sir Run Run Shaw Hospital), Tianhua Zhou(Zhejiang University)
Cited by 344
Abstract
Related Papers
Global Cancer Statistics, 2002
Donald Maxwell Parkin, Freddie Bray, Jacques Ferlay et al.|CA A Cancer Journal for Clinicians|2005|18.4k
A Gain-of-Function Mutation of <i>JAK2</i> in Myeloproliferative Disorders
Róbert Královics, Francesco Passamonti, Andreas Buser et al.|New England Journal of Medicine|2005|3.5k